Epilepsy: A clinical diagnostic overview

European Journal of Pain

Volumn 6, Issue SUPPL. 1, 2002, Pages 21-25

  Sundqvist, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENCE SEIZURE; CLINICAL FEATURE; CLINICAL PRACTICE; COGNITION; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DISEASE COURSE; EPILEPSY; FOCAL EPILEPSY; FREQUENCY ANALYSIS; GENERALIZED EPILEPSY; GRAND MAL EPILEPSY; HEMISPHERE; HUMAN; INCIDENCE; MENTAL DEFICIENCY; MOTOR PERFORMANCE; MYOCLONUS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEIZURE; STATISTICAL SIGNIFICANCE; SYMPTOM; AGE; BRAIN; PATHOLOGY; PATIENT EDUCATION;

ANTICONVULSIVE AGENT;

AGE FACTORS; ANTICONVULSANTS; BRAIN; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; HUMANS; PATIENT EDUCATION;

EID: 0036371444     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1053/eujp.2001.0318     Document Type: Article

References (13)

1. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999; 37: 81-87.
2. Chadwick DW, Anhut H, Greiner MJ, Alexander J, Murray GH et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology 1998; 51: 1282-1288.
3. Commission of Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981; 22: 489-501.
4. Commission of Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-399.
5. Forsgren L. A prospective incidence study and characterization of seizures in newly referred adults. Epilepsia 1990; 31: 292-301.
6. Forsgren L, Bucht G, Eriksson S, Bergmark L. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia 1996; 37: 224-229.
7. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991; 32: 429-445.
8. Kalviainen R, Nousiainen I, Mantyjarvi M, Nikoskelainen E, Partanen J, Partanen K, Riekkinen P Sr. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects. Neurology 1999; 53: 922-926.
9. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997; 38: 859-880.
10. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures. NEJM 1985; 313: 145-51.
11. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine in the treatment of complex partial and secondarily generalized tonic-clonic seizures in adults. NEJM 1992; 327: 765-771.
12. Steinlein O, Mulley JC, Propping P, Wallace RH, Phillips HA, Sutherland GR, Scheffer IE, Berkovic SF. A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Genet 1995; 11: 201-203.
13. Wirrell EC, Camfield CS, Camfield PR, Gordon KE, Dooley JM. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology 1996; 47: 912-928.